🚀 VC round data is live in beta, check it out!

Elevance Health Valuation Multiples

Discover revenue and EBITDA valuation multiples for Elevance Health and similar public comparables like Munich Re, Cigna Group, Tokio Marine, Generali and more.

Elevance Health Overview

About Elevance Health

Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of June 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.


Founded

2001

HQ

United States

Employees

97.1K

Financials (LTM)

Revenue: $197B
EBITDA: $10B

EV

$103B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Elevance Health Financials

Elevance Health reported last 12-month revenue of $197B and EBITDA of $10B.

In the same LTM period, Elevance Health generated $175B in gross profit, $10B in EBITDA, and $6B in net income.

Revenue (LTM)


Elevance Health P&L

In the most recent fiscal year, Elevance Health reported revenue of $199B and net income of $6B.

Elevance Health is profitable as of last fiscal year, with net margin of 3%.

See analyst estimates for Elevance Health
LTMLast FY202320242025202620272028
Revenue$197B$199B$171B$177B$199B
Gross Profit$175B————
Gross Margin89%————
EBITDA$10B————
EBITDA Margin5%————
EBIT Margin4%————
Net Profit$6B$6B$6B$6B$6B
Net Margin3%3%3%3%3%
Net Debt—$23B———

Financial data powered by Morningstar, Inc.

Elevance Health Stock Performance

Elevance Health has current market cap of $81B, and enterprise value of $103B.

Market Cap Evolution


Elevance Health's stock price is $372.68.

Elevance Health share price decreased by 1.0% in the last 30 days, and by 2.9% in the last year.

Elevance Health has an EPS (earnings per share) of $26.07.

See more trading valuation data for Elevance Health
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$103B$81B-1.0%-1.0%16.5%-2.9%$26.07

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Elevance Health Valuation Multiples

Elevance Health trades at 0.5x EV/Revenue multiple, and 10.8x EV/EBITDA.

See NTM and 2027E valuation multiples for Elevance Health

EV / Revenue (LTM)


Elevance Health Financial Valuation Multiples

As of May 2, 2026, Elevance Health has market cap of $81B and EV of $103B.

Elevance Health has a P/E ratio of 12.5x.

LTMLast FY202320242025202620272028
EV/Revenue0.5x0.5x0.6x0.6x0.5x
EV/EBITDA10.8x————
EV/EBIT13.2x————
EV/Gross Profit0.6x————
P/E12.5x14.3x13.5x13.5x14.3x
EV/FCF24.5x32.5x15.2x22.7x32.5x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Elevance Health Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Elevance Health Margins & Growth Rates

In the most recent fiscal year, Elevance Health reported net margin of 3%.

See estimated margins and future growth rates for Elevance Health

Elevance Health Margins

Last FY20242025202720282029
Net Margin3%3%3%
FCF Margin2%3%2%

Elevance Health Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth3%13%
Net Profit Growth(0%)(5%)
FCF Growth(33%)(30%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Elevance Health Operational KPIs

Elevance Health's revenue per employee in the last FY averaged $2.1M.

Access forward-looking KPIs for Elevance Health
LTMLast FY202620272028
Rule of 405%—
Bessemer Rule of X4%—
Revenue per Employee—$2.1M
G&A Expenses to Revenue11%—

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Elevance Health Competitors

Elevance Health competitors include Munich Re, Cigna Group, Tokio Marine, Generali, Manulife, Travelers, AXA, Zurich Insurance Group, Aflac and Allstate.

Most Elevance Health public comparables operate across Insurance Carriers and Health Benefits & Financial Solutions.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Munich Re1.1x1.0x—7.6x
Cigna Group0.4x0.4x—7.7x
Tokio Marine1.4x1.5x8.5x8.6x
Generali0.9x0.9x11.7x11.2x
Manulife1.6x2.0x15.1x14.6x
Travelers1.5x1.7x—9.0x
AXA1.1x1.2x—10.9x
Zurich Insurance Group1.3x1.8x31.9x21.1x

This data is available for Pro users. Sign up to see all Elevance Health competitors and their valuation data.

Start Free Trial

Elevance Health M&A Activity

Elevance Health has acquired 13 companies to date.

Last acquisition by Elevance Health was on February 6th 2025. Elevance Health acquired Granular for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Elevance Health

Granular
CareBridge
Indiana University Health Plans
Centers Plan for Healthy Living
Description
Granular is a New York-based insurtech firm that delivers precision risk management solutions for self-insured employers through its stop-loss insurance products. The company leverages predictive analytics and actuarial modeling to forecast healthcare cost volatility and enable risk-sharing arrangements. Granular partners with reinsurers such as Swiss Re and Munich Re to underwrite policies that cover high-cost claimants. Headquartered in New York City since its founding in 2021, Granular serves mid-market employers across the United States with tailored benefit plans that integrate real-time data from claims and utilization patterns.
CareBridge is a clinical support platform for individuals with physical, intellectual, or developmental disabilities receiving Medicaid or dual Medicare-Medicaid home services. Nashville-headquartered since 2018, it delivers 24/7 assistance to patients, families, and caregivers, ensuring access to equipment and independence at home.
Indiana University Health Plans administers Medicaid managed care, Hoosier Healthwise, Healthy Indiana Plan, and Medicare Advantage products for over 500,000 members in Indiana. Integrated with Indiana University Health's provider network, it coordinates primary care, behavioral health, and pharmacy benefits through hubs in Indianapolis serving urban and rural populations.
Centers Plan for Healthy Living is a New York-based managed care organization administering Medicaid Managed Care, Medicare Advantage, and Fully Integrated Duals Advantage (FIDA) plans. The company serves individuals with intellectual and developmental disabilities, behavioral health needs, and chronic conditions across Long Island and the Hudson Valley region. Centers Plan for Healthy Living coordinates home- and community-based services, long-term care, and primary care through partnerships with healthcare providers.
HQ CountryUnited StatesUnited StatesUnited StatesUnited States
HQ City
Philadelphia, PA
Nashville, TN
Indianapolis, IN
New York City, NY
Deal Date6 Feb 202522 Oct 202411 Sep 202411 Apr 2024
Valuationundisclosed$3Bundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Elevance Health acquisitions and their M&A valuation multiples.

Start Free Trial

Elevance Health Investment Activity

Elevance Health has invested in 9 companies to date.

Latest investment by Elevance Health was on October 8th 2023. Elevance Health invested in Main Street Health in their $315M Undisclosed stage round (EV/Revenue multiple of ).

See VC round multiples

Latest Investments by Elevance Health

Main Street Health
Somatus
Vim
Sera Prognostics
Description
—
Somatus is a McLean-headquartered value-based care provider for kidney disease patients. It integrates clinical services, technology, and nephrology partnerships with health plans to promote home dialysis and transplants. Founded in 2017, the company serves over 100,000 patients through 100 clinics nationwide.
Vim is a New York-headquartered healthcare software company that integrates data into clinical workflows for health plans, providers, and patients. Founded in 2015, Vim connects electronic health records across independent practices and integrated delivery networks, enabling seamless data sharing at the point of care.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
HQ CountryUnited StatesUnited StatesUnited StatesUnited States
HQ City
—
Washington, DC
San Francisco, CA
Salt Lake City, UT
Deal Date8 Oct 202322 Feb 20225 May 202128 Apr 2021
RoundUndisclosed stageSeries ESeries BSeries E
Raised$315M$325M$35M$100M
InvestorsCentene; CVS Health; Echo Health Ventures; Elevance Health; Humana Inc.; LRVHealth; Oak HC/FT; UnitedHealthcareDeerfield; Elevance Health; Fidelity; Flare Capital Partners; GIC; Inova Health System; Longitude Capital; Optum Ventures; RA Capital Management; The Blue Venture Fund; Wellington ManagementAnthem Venture Partners; Elevance Health; Frist Cressey Ventures; GreatPoint Ventures; Optum Ventures; Premera Blue Cross; Sequoia Capital; Walgreens Boots AllianceaMoon Fund; Blue Ox Healthcare Partners; Elevance Health; Parian Global Management; Vivo Capital
Valuation$2B$3Bundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Elevance Health investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Elevance Health

When was Elevance Health founded?Elevance Health was founded in 2001.
Where is Elevance Health headquartered?Elevance Health is headquartered in United States.
How many employees does Elevance Health have?As of today, Elevance Health has over 97K employees.
Who is the CEO of Elevance Health?Elevance Health's CEO is Gail Koziara Boudreaux.
Is Elevance Health publicly listed?Yes, Elevance Health is a public company listed on NYSE.
What is the stock symbol of Elevance Health?Elevance Health trades under ELV ticker.
When did Elevance Health go public?Elevance Health went public in 2001.
Who are competitors of Elevance Health?Elevance Health main competitors include Munich Re, Cigna Group, Tokio Marine, Generali, Manulife, Travelers, AXA, Zurich Insurance Group, Aflac, Allstate.
What is the current market cap of Elevance Health?Elevance Health's current market cap is $81B.
What is the current revenue of Elevance Health?Elevance Health's last 12 months revenue is $197B.
What is the current revenue growth of Elevance Health?Elevance Health revenue growth (NTM/LTM) is (0%).
What is the current EV/Revenue multiple of Elevance Health?Current revenue multiple of Elevance Health is 0.5x.
Is Elevance Health profitable?Yes, Elevance Health is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Elevance Health?Elevance Health's last 12 months EBITDA is $10B.
What is Elevance Health's EBITDA margin?Elevance Health's last 12 months EBITDA margin is 5%.
What is the current EV/EBITDA multiple of Elevance Health?Current EBITDA multiple of Elevance Health is 10.8x.
What is the current FCF of Elevance Health?Elevance Health's last 12 months FCF is $4B.
What is Elevance Health's FCF margin?Elevance Health's last 12 months FCF margin is 2%.
What is the current EV/FCF multiple of Elevance Health?Current FCF multiple of Elevance Health is 24.5x.
How many companies Elevance Health has acquired to date?As of May 2026, Elevance Health has acquired 13 companies.
What was the largest acquisition by Elevance Health?$3B acquisition of CareBridge on 22nd October 2024 was the largest M&A Elevance Health has done to date.
What companies Elevance Health acquired?Elevance Health acquired CareBridge, Paragon Healthcare, Simply Healthcare Holdings, Aspire Health, Centers Plan for Healthy Living, BioPlus Specialty Pharmacy, Beacon Health Options, HealthSun Health Plans, Granular, Indiana University Health Plans, and 3 other companies.
In how many companies Elevance Health has invested to date?As of May 2026, Elevance Health has invested in 9 companies.
What was the last Elevance Health investment?On 8th October 2023 Elevance Health invested in Main Street Health, participating in a $315M Undisclosed stage round at $2B valuation, alongside Centene, CVS Health, Echo Health Ventures, Humana Inc., LRVHealth, Oak HC/FT, and UnitedHealthcare.
In what companies Elevance Health invested in?Elevance Health invested in Somatus, Main Street Health, Sera Prognostics, American Well, K Health, CareBridge, Vim, Linkwell Health, and Movable.

See public comps similar to Elevance Health

Lists including Elevance Health

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial